IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 132 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,352,000 | -16.7% | 123,571 | +3.0% | 0.08% | -20.6% |
| Q1 2019 | $1,623,000 | +84.6% | 119,971 | +41.4% | 0.10% | +70.2% |
| Q4 2018 | $879,000 | +15.1% | 84,869 | +112.2% | 0.06% | +83.9% |
| Q2 2018 | $764,000 | +267.3% | 39,993 | +196.4% | 0.03% | +287.5% |
| Q1 2018 | $208,000 | -84.3% | 13,493 | -84.5% | 0.01% | -89.9% |
| Q4 2016 | $1,328,000 | -66.6% | 86,900 | -71.4% | 0.08% | -60.1% |
| Q2 2016 | $3,977,000 | +83.1% | 304,215 | +53.2% | 0.20% | +104.1% |
| Q1 2016 | $2,172,000 | +126.5% | 198,615 | +139.8% | 0.10% | +115.6% |
| Q4 2015 | $959,000 | -36.0% | 82,815 | -42.5% | 0.04% | -19.6% |
| Q3 2015 | $1,499,000 | -9.2% | 143,915 | +5.1% | 0.06% | +1.8% |
| Q2 2015 | $1,651,000 | +98.0% | 136,921 | +162.5% | 0.06% | +89.7% |
| Q1 2015 | $834,000 | -63.9% | 52,151 | -77.6% | 0.03% | -61.8% |
| Q2 2013 | $2,312,000 | – | 232,876 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |